ES2188932T3 - Formulacion topica de vitamina d a base de liposomas. - Google Patents

Formulacion topica de vitamina d a base de liposomas.

Info

Publication number
ES2188932T3
ES2188932T3 ES97917608T ES97917608T ES2188932T3 ES 2188932 T3 ES2188932 T3 ES 2188932T3 ES 97917608 T ES97917608 T ES 97917608T ES 97917608 T ES97917608 T ES 97917608T ES 2188932 T3 ES2188932 T3 ES 2188932T3
Authority
ES
Spain
Prior art keywords
liposomes
vitamin
formulation
topic formulation
topic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97917608T
Other languages
English (en)
Inventor
Rainer Naeff
Sandro Delmenico
Rene Spycher
Mike Corbo
Frank Flother
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag AG
Original Assignee
Cilag AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag AG filed Critical Cilag AG
Application granted granted Critical
Publication of ES2188932T3 publication Critical patent/ES2188932T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UNA FORMULACION A BASE DE LIPOSOMAS CON UNA BUENA PENETRACION CUTANEA DE LA SUBSTANCIA ACTIVA, PARTICULARMENTE EL CALCITRIOL. ESTA FORMULACION ES MUY ADECUADA PARA EL TRATAMIENTO DE PSORIASIS.
ES97917608T 1996-04-04 1997-03-06 Formulacion topica de vitamina d a base de liposomas. Expired - Lifetime ES2188932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1480596P 1996-04-04 1996-04-04

Publications (1)

Publication Number Publication Date
ES2188932T3 true ES2188932T3 (es) 2003-07-01

Family

ID=21767855

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97917608T Expired - Lifetime ES2188932T3 (es) 1996-04-04 1997-03-06 Formulacion topica de vitamina d a base de liposomas.

Country Status (10)

Country Link
US (1) US5834016A (es)
EP (1) EP0892638B1 (es)
AT (1) ATE227564T1 (es)
AU (1) AU2588297A (es)
CA (1) CA2262870C (es)
DE (1) DE69717095T2 (es)
DK (1) DK0892638T3 (es)
ES (1) ES2188932T3 (es)
PT (1) PT892638E (es)
WO (1) WO1997037637A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE19850074A1 (de) * 1998-10-30 2000-05-04 Dade Behring Marburg Gmbh Stabilisierung von biologischen Flüssigkeiten durch Zusatz von Sterinestern
US6352734B1 (en) * 1999-02-25 2002-03-05 Dreyer's Grand Ice Cream, Inc. Frozen dairy products and methods of production
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
DE60014180T2 (de) * 2000-04-04 2005-10-06 Color Access, Inc. Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
US7235397B1 (en) 2000-04-14 2007-06-26 Gensys, Inc. Methods and compositions for culturing spirochete and treating spirochetal diseases
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
EP1203614A1 (de) * 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
EP1513853A2 (en) * 2002-05-24 2005-03-16 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
US7785623B2 (en) * 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
EP1589977A1 (en) * 2003-01-14 2005-11-02 U.S. Army Medical Research and Material Command Dept. of the Army Topical ointment for vesicating chemical warfare agents
FR2854802B1 (fr) * 2003-05-12 2005-06-24 Galderma Res & Dev Procede de preparation d'une formulation contenant un principe actif microdose
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
EP1706424B1 (en) 2004-01-12 2009-07-22 Applied Molecular Evolution, Inc. Fc region variants
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
AU2006245283B2 (en) 2005-05-10 2012-11-01 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
KR100768151B1 (ko) 2006-04-10 2007-10-17 주식회사 대웅 에스터화 레시딘을 이용한 나노리포좀
KR100752990B1 (ko) 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
EP2152287B1 (en) 2007-05-06 2014-04-02 Sloan Kettering Institute For Cancer Research Methods for treating and preventing gi syndrome and graft versus host disease
FR2917976B1 (fr) * 2007-06-29 2010-05-28 Galderma Sa Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
KR101503461B1 (ko) * 2008-09-08 2015-03-18 주식회사 대웅 화학요법제 유발 탈모증의 예방 또는 치료용 조성물
KR101147600B1 (ko) * 2009-02-09 2012-05-21 한올바이오파마주식회사 콜레칼시페롤 또는 이의 유도체를 함유하는 피부질환 치료용 외용제 조성물
US20110308985A1 (en) * 2009-02-26 2011-12-22 Gina Van Bogaert Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof
WO2012113803A1 (en) * 2011-02-22 2012-08-30 Leo Pharma A/S A cyclic peptide and conjugate thereof for binding to keratinocytes
AU2012275091B2 (en) * 2011-06-29 2017-08-03 Avidas Pharmaceuticals Llc Topical formulations including lipid microcapsule delivery vehicles and their uses
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
CN104000833B (zh) * 2014-03-07 2016-05-18 江西赣南海欣药业股份有限公司 一种维生素d2和果糖酸钙注射剂组合物及其制备方法
SG11202007342QA (en) * 2018-02-15 2020-08-28 Agency Science Tech & Res Methods
US10836788B2 (en) 2019-02-05 2020-11-17 SD Chem, Inc. Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
KR102415735B1 (ko) * 2020-05-26 2022-07-04 (주) 에이치엔에이파마켐 양이온성 고분자 접합체 및 리포좀을 포함하는 3중층 리포좀 조성물, 및 이를 포함하는 화장료 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33107E (en) * 1983-03-22 1989-11-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
IT1240354B (it) * 1990-03-30 1993-12-07 Poli Ind Chimica Spa Formulazioni liposomiali di farmaci antimicotici,antibatterici e/o antantiflogistici per applicazione locale e vaginale
EP0633024A1 (en) * 1993-07-09 1995-01-11 Ciba-Geigy Ag Topically administrable zinc phthalocyanine compositions
EP1008342A3 (en) * 1994-02-02 2004-12-29 The Liposome Company, Inc. Pharmaceutically active compounds and liposomes, and methods of use thereof
US5597575A (en) * 1994-06-06 1997-01-28 Breitbarth; Richard Composition for stimulating and inducing hair growth
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie

Also Published As

Publication number Publication date
AU2588297A (en) 1997-10-29
CA2262870C (en) 2008-01-29
EP0892638B1 (en) 2002-11-13
US5834016A (en) 1998-11-10
CA2262870A1 (en) 1997-10-16
ATE227564T1 (de) 2002-11-15
PT892638E (pt) 2003-03-31
DK0892638T3 (da) 2003-03-03
EP0892638A1 (en) 1999-01-27
DE69717095T2 (de) 2003-07-17
WO1997037637A1 (en) 1997-10-16
DE69717095D1 (de) 2002-12-19

Similar Documents

Publication Publication Date Title
PT892638E (pt) Formulacao topica de vitamina d a base de lipossomas
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
ES2115231T3 (es) Emplasto con sustancias activas.
ES2094034T3 (es) Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion.
AU5485698A (en) Oxyiminopregnancarbolactone
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
BR9803756A (pt) Polimento da unha antipsoriático.
ES2147320T3 (es) Derivados de n-(3-benzofuranil)urea.
ES2179847T3 (es) Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos.
PT1069886E (pt) Formulacoes topica do tipo oleo-em-agua compreendendo um material galactolipidico como emulsionante com um efeito prolongado de uma substancia activa incorporada
PT1028950E (pt) Quinazolina-2,4-dionas 7-substituidas uteis como agentes antibacterianos
DE69801660D1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
AR008860A1 (es) Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica
ES2098164T3 (es) Mezcla sinergetica de al menos un ligando especifico de los rxrs y al menos un ligando especifico de rar-alfa.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
BR0111692A (pt) Processo para preparação de polipeptìdeo il-18 fisiologicamente ativo
IT1255123B (it) Cuscinetto lineare con organi di rotolamento a rotelle a profili curvi
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
ES2058349T3 (es) Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.
ES2076910T3 (es) Producto para el moldeado del cabello a base de nuevos glicerin-esteres.
ES2148600T3 (es) Derivados de indol sustituidos.